A new study reveals a connection between poverty and opioid-related hospitalization, emergency department visits and deaths in Canada. From 2000 to 2017, Canada's poorest residents were 3.8 times more likely to die of opioid-related causes than Canada's richest residents.
A new University of Waterloo study shows that current Hepatitis B vaccination, screening, and treatment strategies in Ontario will leave the province well short of its goal to reduce preventable infections that afflict 1,000 Ontarians annually.
Are COVID-19 drugs recommended for everyone? What are they, and how do they work?
There are four treatment options available for mild cases of COVID-19.
Kelly Grindrod, a pharmacist and University of Waterloo professor, answers common questions about these medications.
Camille was recognized for her outstanding work term contributions and supporting the vaccination campaign
Congratulations to Professors Andrea Edginton, Anna Klinkova and Rebecca Rooney for being awarded the 2022 Faculty of Science Excellence in Science Research Awards!
Decisions about COVID-19 vaccinations often come down to trust.
Trust in peer networks, in the information available to a person and in the health-care system as a whole.
Since 2018, the Graduate Studies and Postdoctoral Affairs (GSPA) hosts a "GRADflix" competition, challenging students from across campus to communicate their research to a general audience. With only 60 seconds at their disposal, competitors create videos, moving slideshows or animation, in order to tell us why their research is important!
Omicron is the latest COVID-19 variant of concern, and it is expected to change the course of the pandemic. But how are variants formed, and what’s the threat level for people who are fully vaccinated? Kelly Grindrod, a pharmacist and professor, and Trevor Charles, a professor in the University of Waterloo’s Department of Biology, provide answers to these questions.
Ontarians with chronic hepatitis C can lose up to 20 per cent of their overall income managing their condition, a new study has found.
Using survey results from 275 patients, the study analyzed the financial burden of chronic hepatitis C (CHC) on patients treated in hospital and community clinics.
The research team determined that patients treated in hospital hepatitis clinics spent up to five times more out-of-pocket on supporting their CHC needs than those treated in community hepatitis clinics.
Vision is one of our most dominant senses, and our world is often built around our ability to see. Despite this, the World Health Organization reports that more than one third of people around the world suffer from some form of vision impairment or blindness. Of these estimated 2.2 billion people, at least one billion of these cases could have been prevented or have not been addressed yet.